1. Effects of tetrahedral DNA nanostructures on autophagy in chondrocytes
    Sirong Shi et al, 2018, Chem. Commun. CrossRef
  2. Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic–Ischemic Brain Injury
    Liu Tu et al, 2018, Neurochem Res CrossRef
  3. Ginseng Total Saponin Attenuates Podocyte Apoptosis Induced by Diabetic Conditions Through the Recovery of CD2-Associated Protein
    Tae-Sun Ha et al, 2019, Journal of Medicinal Food CrossRef
  4. FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose
    Chenlin Gao et al, 2019, BioMed Research International CrossRef
  5. Notoginsenoside R1 alleviates lipopolysaccharide-triggered PC-12 inflammatory damage via elevating microRNA-132
    Yuanliang Sun et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  6. Notoginsenoside R1 protects human renal proximal tubular epithelial cells from lipopolysaccharide-stimulated inflammatory damage by up-regulation of miR-26a
    Jinrong Liu et al, 2019, Chemico-Biological Interactions CrossRef
  7. Sense Ginsenosides From Ginsengs: Structure-Activity Relationship in Autophagy
    Tao Wu et al, 2019, Natural Product Communications CrossRef
  8. Notoginsenoside Fc Accelerates Reendothelialization following Vascular Injury in Diabetic Rats by Promoting Endothelial Cell Autophagy
    Jingjing Liu et al, 2019, Journal of Diabetes Research CrossRef
  9. Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503
    Weiwei Wang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  10. Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment
    Nidhi Raval et al, 2019, Sci Rep CrossRef
  11. Autophagy Function and Regulation in Kidney Disease.
    Gur P Kaushal et al, 2020, Biomolecules CrossRef
  12. Vitexin induces G2/M‑phase arrest and apoptosis via Akt/mTOR signaling pathway in human glioblastoma cells
    Guangning Zhang et al, 2018, Mol Med Report CrossRef
  13. Overexpression of miR‑130a‑3p/301a‑3p attenuates high glucose‑induced MPC5 podocyte dysfunction through suppression of TNF‑α signaling
    Yan Jiang et al, 2017, Exp Ther Med CrossRef
  14. The Rab-Rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II
    Olga Martinez-Arroyo et al, 2020, American Journal of Physiology-Renal Physiology CrossRef
  15. Exploring microRNAs in diabetic chronic cutaneous ulcers: Regulatory mechanisms and therapeutic potential
    Xuqiang Nie et al, 2020, Br J Pharmacol CrossRef
  16. Sanqi Oral Solution Ameliorates Renal Ischemia/Reperfusion Injury via Reducing Apoptosis and Enhancing Autophagy: Involvement of ERK/mTOR Pathways
    Ruimin Tian et al, 2020, Front. Pharmacol. CrossRef
  17. Notoginsenoside R1 alleviates TEGDMA-induced mitochondrial apoptosis in preodontoblasts through activation of Akt/Nrf2 pathway-dependent mitophagy
    Konghuai Wang et al, 2021, Toxicology and Applied Pharmacology CrossRef
  18. Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
    Yi Ou et al, 2021 CrossRef
  19. Notoginsenoside R1 suppresses inflammatory response and the pyroptosis of nucleus pulposus cells via inactivating NF-κB/NLRP3 pathways
    Kai Tang et al, 2021, International Immunopharmacology CrossRef
  20. Tripterygium glycoside ameliorates kidney injury in diabetic rats by regulating the PI3K/Akt signaling pathway
    Dandan HOU et al, 2022, Food Sci. Technol CrossRef
  21. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway
    Di Jin et al, 2022, Journal of Ethnopharmacology CrossRef
  22. Recent advances in the managements of type 2 diabetes mellitus and natural hypoglycemic substances
    Chong Ning et al, 2022, Food Science and Human Wellness CrossRef
  23. Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway
    Wei Lei et al, 2022, Front. Pharmacol. CrossRef
  24. The Protective Effect of Notoginsenoside R1 on Isoflurane-Induced Neurological Impairment in the Rats via Regulating miR-29a Expression and Neuroinflammation.
    Meijing Wang et al, 2022, Neuroimmunomodulation CrossRef
  25. Solasonine alleviates high glucose‐induced podocyte injury through increasing Nrf2‐medicated inhibition of NLRP3 activation
    Qianjin Zhang et al, 2022, Drug Development Research CrossRef
  26. Potential therapeutic effects of natural compounds targeting autophagy to alleviate podocyte injury in glomerular diseases
    Tongtong Liu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  27. The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.
    Bing Zhang et al, 2018, Cell Death Dis CrossRef
  28. Notoginsenoside R1 Facilitates Cell Angiogenesis by Inactivating the Notch Signaling During Wound Healing
    Dongjin Li et al, 2023 CrossRef
  29. Radix puerariae in the treatment of diabetic nephropathy: A network pharmacology analysis and experimental validation
    Cheng Li et al, 2023 CrossRef
  30. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
    Can Yang et al, 2023, Mol Med CrossRef
  31. Notoginsenoside R1 restrains the proliferation and migration of airway smooth muscle cells isolated from rats with chronic obstructive pulmonary disease
    Xiaoyong Li et al, 2024, Inhalation Toxicology CrossRef
  32. Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy
    Fengzhao Liu et al, 2024, Front. Pharmacol. CrossRef
  33. Investigation of Ginseng-Ophiopogon Injection on Enhancing Physical Function by Pharmacogenomics and Metabolomics Evaluation
    Chen Meimei et al, 2024, CCHTS CrossRef
  34. Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
    Fengzhao Liu et al, 2024, Mol Med CrossRef
  35. Pharmacokinetics and Biological Activities of Notoginsenoside R1: A Systematical Review
    Chao Wen et al, 2025, Am. J. Chin. Med. CrossRef